December 12, 2024 - 04:04

Xavier sophomore guard Trey Green has announced an indefinite leave of absence from the Musketeers basketball team to focus on a health-related issue. This decision comes as the team prepares for the upcoming challenges in their season, and it highlights the importance of prioritizing mental and physical well-being in the high-pressure environment of college athletics.
Green, who has shown promise in his early career at Xavier, will be missed by his teammates and coaching staff during this time. His contributions on the court have been significant, and his absence will undoubtedly be felt as the team navigates its schedule. The Musketeers will need to adapt in order to fill the gap left by Green’s departure, both in terms of scoring and playmaking.
As the situation develops, the university and the basketball program have expressed their support for Green, emphasizing that health comes first. Fans and supporters of the program are hopeful for his swift return to the court once he has addressed his health concerns.
October 21, 2026 - 01:41
Ebola Case Confirmed in Abuja After Traveler Arrives From UgandaNigeria has confirmed an Ebola case in Abuja after a woman arriving from Uganda tested positive, making the country the latest in the region to report an infection as the outbreak continues to...
October 20, 2026 - 03:18
CIM Holds Annual Health and Benefits Fair for StaffThe California Institution for Men in Chino recently hosted its yearly Employee Health and Benefits Fair, giving staff a chance to learn about the resources available to them and their...
October 19, 2026 - 05:23
Health Officials Push for Flu Vaccinations as Early Cases Rise in Some StatesVirginia health officials are urging residents to get their flu shots as data from other parts of the country points to an early jump in infections this season. So far, only about 10 percent of...
October 18, 2026 - 21:18
VA Doctor Leads National Trial on GLP-1 Drugs for Alcohol Use DisorderA physician at the Philadelphia Veterans Affairs Medical Center is heading a nationwide clinical trial that will examine whether GLP-1 receptor agonists, the class of medications best known for...